Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Todd Pitts

Concepts (396)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
24
2024
748
2.910
 Why?
Xenograft Model Antitumor Assays
38
2024
808
2.010
 Why?
Protein Kinase Inhibitors
19
2020
886
1.860
 Why?
Antineoplastic Agents
25
2020
2045
1.450
 Why?
Triple Negative Breast Neoplasms
7
2024
193
1.430
 Why?
Azepines
5
2024
88
1.390
 Why?
Histone Deacetylase Inhibitors
5
2024
209
1.240
 Why?
Pyrimidines
9
2020
458
1.170
 Why?
Cell Line, Tumor
37
2025
3185
1.160
 Why?
Mice, Nude
25
2024
680
1.140
 Why?
Pyrazines
6
2018
87
1.010
 Why?
Cell Proliferation
22
2024
2378
0.950
 Why?
Pancreatic Neoplasms
6
2024
879
0.900
 Why?
Carcinoma, Pancreatic Ductal
2
2024
269
0.840
 Why?
Apoptosis
22
2024
2489
0.770
 Why?
Fluorouracil
1
2022
197
0.740
 Why?
Proto-Oncogene Proteins
6
2018
634
0.630
 Why?
Benzimidazoles
6
2024
162
0.630
 Why?
Camptothecin
5
2022
110
0.620
 Why?
Imidazoles
4
2018
235
0.620
 Why?
Aurora Kinase A
4
2020
53
0.620
 Why?
Drug Resistance, Neoplasm
12
2024
753
0.590
 Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1560
0.570
 Why?
Drug Synergism
4
2014
370
0.550
 Why?
Mice
42
2025
16983
0.540
 Why?
Neoplasms
9
2022
2454
0.520
 Why?
Cell Cycle Proteins
2
2018
583
0.500
 Why?
Wnt Signaling Pathway
5
2024
170
0.490
 Why?
Cell Cycle Checkpoints
3
2019
96
0.480
 Why?
Hydroxamic Acids
3
2011
88
0.480
 Why?
Deoxycytidine
3
2024
164
0.480
 Why?
Melanoma
5
2024
730
0.470
 Why?
Animals
47
2025
35409
0.460
 Why?
Receptor, IGF Type 1
3
2013
64
0.460
 Why?
Disease Models, Animal
11
2025
4077
0.460
 Why?
Pyrazoles
5
2018
403
0.450
 Why?
Gene Expression Regulation, Neoplastic
10
2024
1327
0.440
 Why?
Adrenocortical Carcinoma
3
2020
63
0.440
 Why?
Tumor Microenvironment
5
2022
627
0.440
 Why?
Antimitotic Agents
1
2013
8
0.440
 Why?
Tumor Suppressor Protein p53
5
2024
503
0.430
 Why?
Mitogen-Activated Protein Kinases
3
2014
312
0.430
 Why?
Molecular Targeted Therapy
3
2024
391
0.420
 Why?
Signal Transduction
18
2024
4935
0.410
 Why?
G2 Phase Cell Cycle Checkpoints
4
2022
45
0.410
 Why?
TOR Serine-Threonine Kinases
2
2018
398
0.400
 Why?
Cyclin-Dependent Kinases
1
2013
126
0.400
 Why?
Boronic Acids
2
2011
37
0.390
 Why?
Quinoxalines
4
2020
64
0.370
 Why?
Dasatinib
2
2024
54
0.360
 Why?
Gene Expression Profiling
8
2024
1686
0.350
 Why?
Colonic Neoplasms
2
2013
241
0.350
 Why?
Biomarkers, Tumor
6
2018
1161
0.340
 Why?
Humans
67
2025
129847
0.340
 Why?
Drug Screening Assays, Antitumor
5
2020
191
0.340
 Why?
Heterografts
3
2021
134
0.330
 Why?
Programmed Cell Death 1 Receptor
3
2025
232
0.330
 Why?
Oxidoreductases Acting on CH-CH Group Donors
2
2020
25
0.320
 Why?
Phosphatidylinositol 3-Kinases
6
2018
362
0.300
 Why?
Adrenal Cortex Neoplasms
2
2020
60
0.290
 Why?
Cell Cycle
7
2018
583
0.280
 Why?
Ephrin-B2
2
2019
50
0.280
 Why?
Enzyme Inhibitors
5
2020
827
0.280
 Why?
Piperazines
2
2020
339
0.280
 Why?
Drug Delivery Systems
1
2010
337
0.270
 Why?
Antibodies, Monoclonal, Humanized
2
2024
756
0.270
 Why?
Quinazolines
3
2015
243
0.270
 Why?
Female
41
2025
68829
0.260
 Why?
Anilides
2
2018
70
0.250
 Why?
Oncogene Proteins, Fusion
2
2018
201
0.250
 Why?
Mitogen-Activated Protein Kinase Kinases
3
2019
131
0.250
 Why?
Organoids
2
2024
104
0.240
 Why?
Mutation
9
2018
3706
0.240
 Why?
Gene Dosage
4
2015
143
0.240
 Why?
Nephritis, Interstitial
1
2025
13
0.230
 Why?
Gene Regulatory Networks
2
2024
280
0.230
 Why?
Immunoblotting
6
2015
306
0.230
 Why?
Cyclosporine
2
2018
263
0.230
 Why?
Pyrimidinones
2
2015
102
0.230
 Why?
Proto-Oncogene Proteins B-raf
3
2018
210
0.220
 Why?
RNA, Small Interfering
2
2024
590
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2020
204
0.220
 Why?
ras Proteins
4
2013
143
0.220
 Why?
Endogenous Retroviruses
1
2024
34
0.220
 Why?
Bevacizumab
1
2024
128
0.220
 Why?
Proto-Oncogene Proteins p21(ras)
6
2016
259
0.220
 Why?
Pyridones
2
2015
158
0.210
 Why?
Receptor, Notch1
2
2015
62
0.210
 Why?
Mucous Membrane
1
2024
125
0.210
 Why?
Neoplasm Transplantation
4
2018
253
0.210
 Why?
Pyridines
2
2018
478
0.200
 Why?
Paclitaxel
1
2024
218
0.200
 Why?
Antineoplastic Agents, Immunological
3
2020
181
0.200
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
65
0.200
 Why?
HCT116 Cells
3
2018
76
0.200
 Why?
Immunotherapy
3
2022
596
0.200
 Why?
Doxorubicin
1
2024
329
0.190
 Why?
Drug Design
2
2013
158
0.190
 Why?
beta Catenin
2
2020
224
0.190
 Why?
Gene Knockdown Techniques
4
2020
317
0.180
 Why?
Momordica charantia
1
2020
15
0.170
 Why?
DNA-Binding Proteins
2
2020
1441
0.170
 Why?
Benzoxazoles
1
2020
20
0.170
 Why?
HT29 Cells
2
2018
36
0.170
 Why?
Neoplasms, Experimental
2
2019
171
0.160
 Why?
Immune System
1
2021
175
0.160
 Why?
eIF-2 Kinase
1
2019
30
0.160
 Why?
src-Family Kinases
2
2017
95
0.160
 Why?
Inhibitory Concentration 50
2
2016
86
0.150
 Why?
Receptor, EphB4
1
2019
36
0.150
 Why?
Tumor Burden
2
2018
287
0.150
 Why?
DNA Helicases
1
2020
146
0.150
 Why?
Breast Neoplasms, Male
1
2018
28
0.150
 Why?
Plant Extracts
1
2020
198
0.150
 Why?
Coenzymes
1
2018
20
0.150
 Why?
4-Aminobenzoic Acid
1
2018
7
0.150
 Why?
Neoplasm Proteins
2
2020
417
0.150
 Why?
Thermodynamics
1
2020
407
0.140
 Why?
MAP Kinase Kinase Kinases
2
2015
70
0.140
 Why?
Septins
1
2018
43
0.140
 Why?
Adrenal Cortex
1
2018
27
0.140
 Why?
Oncogene Proteins v-abl
1
2017
5
0.140
 Why?
Neoplasm Invasiveness
3
2020
484
0.140
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
33
0.140
 Why?
Kidney
1
2025
1383
0.140
 Why?
Angiogenesis Inhibitors
3
2018
218
0.140
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2014
84
0.130
 Why?
Ubiquitin-Activating Enzymes
1
2016
16
0.130
 Why?
Cyclopentanes
1
2016
19
0.130
 Why?
Skin Neoplasms
1
2024
830
0.130
 Why?
Transplantation, Heterologous
4
2022
191
0.130
 Why?
Tumor Cells, Cultured
4
2020
931
0.130
 Why?
Corynebacterium
1
2017
48
0.130
 Why?
Corynebacterium Infections
1
2017
40
0.130
 Why?
Tankyrases
1
2016
14
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
310
0.130
 Why?
Cetuximab
1
2016
94
0.130
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
117
0.120
 Why?
Capecitabine
1
2015
45
0.120
 Why?
Autophagy
1
2018
266
0.120
 Why?
Biliary Tract Neoplasms
1
2015
25
0.120
 Why?
Amyloid Precursor Protein Secretases
2
2013
80
0.120
 Why?
Drug Discovery
1
2016
131
0.120
 Why?
Genes, ras
2
2018
95
0.120
 Why?
Adenocarcinoma
2
2020
893
0.120
 Why?
Cell Survival
3
2019
1086
0.120
 Why?
Diphenylamine
1
2014
9
0.120
 Why?
Gene Expression Regulation
1
2024
2545
0.110
 Why?
Germ-Line Mutation
2
2018
140
0.110
 Why?
Middle Aged
14
2024
31177
0.110
 Why?
DNA Copy Number Variations
1
2015
167
0.110
 Why?
Piperidines
1
2015
200
0.110
 Why?
Proto-Oncogene Proteins c-met
1
2014
74
0.110
 Why?
Benzamides
1
2014
203
0.110
 Why?
Aged
11
2024
22107
0.110
 Why?
Urinary Bladder Neoplasms
1
2016
226
0.110
 Why?
Protein Kinases
1
2015
318
0.110
 Why?
Up-Regulation
1
2016
836
0.110
 Why?
Receptor, Insulin
1
2013
99
0.100
 Why?
Tetrahydronaphthalenes
1
2013
30
0.100
 Why?
Valine
1
2013
81
0.100
 Why?
Neutrophils
4
2019
1209
0.100
 Why?
Bortezomib
2
2011
45
0.100
 Why?
Receptors, Notch
1
2013
84
0.100
 Why?
Mitosis
1
2013
180
0.100
 Why?
Tumor Suppressor Proteins
1
2015
311
0.100
 Why?
Antineoplastic Agents, Phytogenic
1
2013
187
0.090
 Why?
3' Untranslated Regions
1
2012
138
0.090
 Why?
Head and Neck Neoplasms
1
2016
544
0.090
 Why?
Carcinoma, Squamous Cell
1
2016
628
0.090
 Why?
Aldehyde Dehydrogenase
1
2012
101
0.090
 Why?
Computational Biology
1
2015
593
0.090
 Why?
Sirolimus
1
2013
270
0.090
 Why?
Proteasome Inhibitors
1
2011
42
0.090
 Why?
Benzodioxoles
1
2012
106
0.090
 Why?
Carcinogenesis
2
2024
214
0.080
 Why?
Protease Inhibitors
1
2011
107
0.080
 Why?
Proto-Oncogene Proteins c-akt
4
2018
434
0.080
 Why?
Nuclear Proteins
1
2015
660
0.080
 Why?
Neoplasm Metastasis
3
2018
610
0.080
 Why?
Mice, Inbred NOD
2
2022
587
0.080
 Why?
Phosphorylation
4
2019
1716
0.080
 Why?
Adult
12
2024
35634
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
7
0.080
 Why?
Breast Neoplasms
2
2012
2104
0.080
 Why?
Mice, Inbred BALB C
3
2020
1248
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
70
0.080
 Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
81
0.080
 Why?
Male
15
2024
63759
0.080
 Why?
Gastrointestinal Neoplasms
1
2009
72
0.080
 Why?
Carcinoma, Hepatocellular
1
2011
270
0.080
 Why?
Cell Movement
2
2011
950
0.070
 Why?
Positron-Emission Tomography
3
2018
282
0.070
 Why?
Immunosuppressive Agents
1
2013
858
0.070
 Why?
Prognosis
4
2019
3773
0.070
 Why?
Farnesyltranstransferase
1
2007
35
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
756
0.070
 Why?
Feasibility Studies
1
2010
870
0.060
 Why?
Protein Conformation
2
2020
861
0.060
 Why?
Algorithms
3
2024
1617
0.060
 Why?
Transcription, Genetic
2
2024
1416
0.060
 Why?
Gene Expression
2
2019
1465
0.060
 Why?
Microsatellite Repeats
2
2024
163
0.060
 Why?
Maximum Tolerated Dose
2
2020
193
0.060
 Why?
Reproducibility of Results
2
2010
3089
0.060
 Why?
Quinolones
1
2007
127
0.060
 Why?
Ipilimumab
1
2025
31
0.060
 Why?
Neovascularization, Pathologic
2
2018
297
0.060
 Why?
CTLA-4 Antigen
1
2025
87
0.060
 Why?
Models, Molecular
2
2020
1488
0.060
 Why?
Structure-Activity Relationship
2
2018
549
0.050
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2019
40
0.050
 Why?
Enhancer Elements, Genetic
1
2024
177
0.050
 Why?
Triazoles
1
2024
148
0.050
 Why?
Magnetic Resonance Spectroscopy
2
2018
541
0.050
 Why?
HMGB1 Protein
1
2003
49
0.050
 Why?
Adrenergic alpha-Agonists
1
2002
28
0.050
 Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.050
 Why?
Adrenergic alpha-Antagonists
1
2002
33
0.050
 Why?
Neuroimmunomodulation
1
2002
67
0.050
 Why?
Histones
2
2022
588
0.050
 Why?
Treatment Outcome
4
2024
10241
0.050
 Why?
Histone Deacetylase 1
1
2022
24
0.050
 Why?
Isoenzymes
1
2003
301
0.050
 Why?
Aurora Kinases
2
2012
27
0.050
 Why?
Adrenergic beta-Agonists
1
2002
133
0.050
 Why?
Endotoxemia
1
2002
85
0.050
 Why?
Genetic Predisposition to Disease
1
2010
2271
0.050
 Why?
Caspase 3
2
2013
244
0.050
 Why?
Chimerism
1
2021
31
0.040
 Why?
Acetylation
1
2022
244
0.040
 Why?
Flow Cytometry
2
2019
1160
0.040
 Why?
Campylobacter jejuni
1
2000
11
0.040
 Why?
Lymphoid Tissue
1
2021
67
0.040
 Why?
Lymphocyte Subsets
1
2021
84
0.040
 Why?
Cluster Analysis
2
2012
483
0.040
 Why?
Catalase
1
2000
128
0.040
 Why?
TCF Transcription Factors
1
2020
16
0.040
 Why?
Adrenergic beta-Antagonists
1
2002
321
0.040
 Why?
Histone Deacetylases
1
2022
212
0.040
 Why?
Mice, SCID
1
2021
350
0.040
 Why?
RNA, Neoplasm
1
2020
82
0.040
 Why?
Antimetabolites, Antineoplastic
1
2020
91
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Indolizines
1
2019
4
0.040
 Why?
Forkhead Box Protein M1
1
2019
7
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
118
0.040
 Why?
Small Molecule Libraries
1
2020
86
0.040
 Why?
Genomics
1
2024
716
0.040
 Why?
MAP Kinase Kinase 2
2
2013
28
0.040
 Why?
Crystallography, X-Ray
1
2020
438
0.040
 Why?
MAP Kinase Kinase 1
2
2013
75
0.040
 Why?
High-Throughput Screening Assays
1
2020
139
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Genetic Linkage
1
1999
296
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
16
0.040
 Why?
NADP
1
2018
47
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
201
0.040
 Why?
Radiotherapy
1
2019
185
0.040
 Why?
Multifactorial Inheritance
1
1999
150
0.040
 Why?
Nausea
1
2018
111
0.040
 Why?
Aldosterone
1
2018
43
0.040
 Why?
Hemorrhage
1
2002
680
0.040
 Why?
Kaplan-Meier Estimate
1
2020
851
0.040
 Why?
DNA Damage
1
2020
383
0.040
 Why?
Area Under Curve
1
2018
306
0.040
 Why?
Drug Therapy, Combination
1
2020
1042
0.030
 Why?
Breast
1
2018
140
0.030
 Why?
RNA
1
2024
877
0.030
 Why?
Diarrhea
1
2018
181
0.030
 Why?
Catalytic Domain
1
2018
218
0.030
 Why?
Autistic Disorder
1
1999
189
0.030
 Why?
Recombinant Proteins
1
2020
1311
0.030
 Why?
Disease-Free Survival
1
2018
647
0.030
 Why?
RNA, Messenger
2
2020
2703
0.030
 Why?
Axin Protein
1
2016
19
0.030
 Why?
Ubiquitination
1
2016
98
0.030
 Why?
Fatigue
1
2018
319
0.030
 Why?
Sequence Analysis, RNA
1
2018
426
0.030
 Why?
T-Lymphocytes, Regulatory
1
2019
373
0.030
 Why?
Administration, Oral
1
2018
787
0.030
 Why?
Protein Isoforms
1
2017
393
0.030
 Why?
Hypertension
2
2018
1242
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
577
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Gene Duplication
1
2015
67
0.030
 Why?
Binding Sites
1
2018
1251
0.030
 Why?
Immunohistochemistry
1
2019
1690
0.030
 Why?
Biopsy
1
2018
1089
0.030
 Why?
NF-kappa B
3
2003
666
0.030
 Why?
Databases, Genetic
1
2015
228
0.030
 Why?
Mice, Knockout
1
2021
2888
0.030
 Why?
Calcium-Binding Proteins
1
2015
213
0.030
 Why?
Caspase 7
1
2013
22
0.030
 Why?
Butadienes
1
2013
36
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
373
0.030
 Why?
Cell Growth Processes
1
2013
51
0.030
 Why?
Survival Analysis
1
2016
1271
0.030
 Why?
Tumor Stem Cell Assay
1
2012
32
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2019
855
0.030
 Why?
Everolimus
1
2013
88
0.030
 Why?
Nitriles
1
2013
169
0.020
 Why?
Phenotype
1
2021
3062
0.020
 Why?
Random Allocation
1
2013
347
0.020
 Why?
Neoplasm Staging
1
2015
1282
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
2
2003
141
0.020
 Why?
Immunoprecipitation
1
2012
156
0.020
 Why?
p38 Mitogen-Activated Protein Kinases
2
2003
277
0.020
 Why?
Calcium Signaling
1
2013
252
0.020
 Why?
Kinetics
1
2014
1645
0.020
 Why?
Cellular Senescence
1
2012
173
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
307
0.020
 Why?
Enzyme Activation
2
2003
813
0.020
 Why?
PTEN Phosphohydrolase
1
2012
159
0.020
 Why?
Disease Progression
1
2018
2628
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
149
0.020
 Why?
Li-Fraumeni Syndrome
1
2010
13
0.020
 Why?
Receptor, ErbB-2
1
2012
325
0.020
 Why?
Molecular Epidemiology
1
2010
63
0.020
 Why?
Neutropenia
1
2010
137
0.020
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
260
0.020
 Why?
Population Groups
1
2010
60
0.020
 Why?
Ki-67 Antigen
1
2010
108
0.020
 Why?
Metabolome
1
2013
339
0.020
 Why?
Ligands
1
2011
621
0.020
 Why?
Capillary Permeability
1
2010
141
0.020
 Why?
Transcriptome
1
2015
875
0.020
 Why?
Drug Combinations
1
2010
331
0.020
 Why?
Australia
1
2010
243
0.020
 Why?
Keratinocytes
1
2010
244
0.020
 Why?
Membrane Proteins
1
2015
1119
0.020
 Why?
Antibodies, Monoclonal
1
2015
1368
0.020
 Why?
Biomarkers
1
2019
3971
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
954
0.020
 Why?
Sulfonamides
1
2011
497
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2007
13
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
836
0.020
 Why?
Verapamil
1
2007
41
0.020
 Why?
Calcium
1
2013
1212
0.020
 Why?
Blotting, Western
1
2009
1204
0.020
 Why?
Magnetic Resonance Imaging
1
2018
3397
0.020
 Why?
Clone Cells
1
2007
262
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
2016
0.020
 Why?
Calcium Channel Blockers
1
2007
161
0.020
 Why?
Liver Neoplasms
1
2011
636
0.020
 Why?
Family
1
2010
646
0.020
 Why?
Metabolomics
1
2011
652
0.020
 Why?
MicroRNAs
1
2012
680
0.020
 Why?
Cohort Studies
1
2015
5444
0.020
 Why?
Ovarian Neoplasms
1
2010
482
0.010
 Why?
Phosphotransferases
1
2003
24
0.010
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
 Why?
bcl-Associated Death Protein
1
2003
10
0.010
 Why?
Phentolamine
1
2002
14
0.010
 Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.010
 Why?
Brimonidine Tartrate
1
2002
9
0.010
 Why?
Adolescent
2
2018
20451
0.010
 Why?
Propranolol
1
2002
50
0.010
 Why?
Phenylephrine
1
2002
75
0.010
 Why?
Mice, Mutant Strains
1
2003
298
0.010
 Why?
Chemokines
1
2003
227
0.010
 Why?
Peroxidase
1
2002
175
0.010
 Why?
Young Adult
1
2018
12467
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
2002
151
0.010
 Why?
Biological Transport
1
2003
405
0.010
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
232
0.010
 Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
133
0.010
 Why?
Respiratory Burst
1
2000
15
0.010
 Why?
omega-N-Methylarginine
1
2000
26
0.010
 Why?
MAP Kinase Signaling System
1
2002
314
0.010
 Why?
Inflammation Mediators
1
2003
505
0.010
 Why?
Protein Processing, Post-Translational
1
2002
457
0.010
 Why?
Statistical Distributions
1
1999
8
0.010
 Why?
Cloning, Molecular
1
2000
524
0.010
 Why?
Matched-Pair Analysis
1
1999
40
0.010
 Why?
Intelligence Tests
1
1999
57
0.010
 Why?
Chromosomes, Human
1
1999
41
0.010
 Why?
Nuclear Family
1
1999
51
0.010
 Why?
Lipopolysaccharides
1
2003
872
0.010
 Why?
Protein-Tyrosine Kinases
1
2002
431
0.010
 Why?
Hydrogen Peroxide
1
2000
317
0.010
 Why?
Linkage Disequilibrium
1
1999
257
0.010
 Why?
Carrier Proteins
1
2003
741
0.010
 Why?
Models, Genetic
1
1999
592
0.010
 Why?
Cells, Cultured
1
2003
4102
0.010
 Why?
Cell Line
1
2000
2780
0.010
 Why?
Cytokines
1
2003
2022
0.010
 Why?
Molecular Sequence Data
1
1999
2833
0.010
 Why?
Genotype
1
1999
1829
0.010
 Why?
Sex Factors
1
1999
1973
0.010
 Why?
Macrophages
1
2000
1489
0.010
 Why?
Mice, Inbred C57BL
1
2003
5468
0.010
 Why?
Child, Preschool
1
1999
10522
0.000
 Why?
Child
1
1999
20962
0.000
 Why?
Pitts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (396) concept(s)
_
Co-Authors Expand Description
See all (84) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)